FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagehl7.fhir.uv.cqm.r4b
Resource TypeMeasure
IdMeasure-measure-cqm-publishable-example.json
FHIR VersionR4B

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source

Metadata
Title Measure CQM Publishable Example
Version 1.0.0
Short Name ExampleMeasure001
GUID (Version Independent) urn:uuid:aaa111
GUID (Version Specific) urn:uuid:aaa111-v1
Identifier urn:oid:2.16.840.1.113883.4.642.40.61.29.21
Experimental true
Jurisdiction Global (Whole world)
Steward (Publisher) HL7 International / Clinical Quality Information
Description

A measure to demonstrate limitations and trendingIssues extensions.

Measure Group (Rate)
Initial Population ID: initial-population
Description:

All inpatient encounters, as well as ED and OBS encounters that end within 1 hour of the start of the inpatient encounter, for patients of all ages where at least one antidiabetic drug (ADD) was ordered or administered during the encounter that is during the measurement period.

Criteria: Initial Population
Generated using version 0.4.9 of the sample-content-ig Liquid templates

Source1

{
  "resourceType": "Measure",
  "id": "measure-cqm-publishable-example",
  "meta": {
    "profile": [
      "http://hl7.org/fhir/uv/cqm/StructureDefinition/cqm-publishablemeasure"
    ]
  },
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/uv/cqm/StructureDefinition/cqm-limitations",
      "valueMarkdown": "This measure may not be accurate in regions with incomplete EHR data reporting."
    },
    {
      "url": "http://hl7.org/fhir/uv/cqm/StructureDefinition/cqm-trendingIssues",
      "valueMarkdown": "Recent changes in ICD-10 coding may affect comparison with historical data."
    }
  ],
  "url": "http://hl7.org/fhir/uv/cqm/Measure/measure-cqm-publishable-example",
  "identifier": [
    {
      "use": "official",
      "type": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/artifact-identifier-type",
            "code": "version-independent"
          }
        ]
      },
      "system": "urn:ietf:rfc:3986",
      "value": "urn:uuid:aaa111"
    },
    {
      "use": "official",
      "type": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/artifact-identifier-type",
            "code": "version-specific"
          }
        ]
      },
      "system": "urn:ietf:rfc:3986",
      "value": "urn:uuid:aaa111-v1"
    },
    {
      "use": "usual",
      "type": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/artifact-identifier-type",
            "code": "short-name"
          }
        ]
      },
      "value": "ExampleMeasure001"
    },
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.4.642.40.61.29.21"
    }
  ],
  "version": "1.0.0",
  "name": "MeasureCQMPublishableExample",
  "title": "Measure CQM Publishable Example",
  "status": "active",
  "experimental": true,
  "date": "2025-07-17",
  "publisher": "HL7 International / Clinical Quality Information",
  "contact": [
    {
      "telecom": [
        {
          "system": "url",
          "value": "http://www.hl7.org/Special/committees/cqi"
        }
      ]
    }
  ],
  "description": "A measure to demonstrate limitations and trendingIssues extensions.",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
          "code": "001"
        }
      ]
    }
  ],
  "group": [
    {
      "population": [
        {
          "id": "initial-population",
          "code": {
            "coding": [
              {
                "system": "http://terminology.hl7.org/CodeSystem/measure-population",
                "code": "initial-population",
                "display": "Initial Population"
              }
            ]
          },
          "description": "All inpatient encounters, as well as ED and OBS encounters that end within 1 hour of the start of the inpatient encounter, for patients of all ages where at least one antidiabetic drug (ADD) was ordered or administered during the encounter that is during the measurement period.",
          "criteria": {
            "language": "text/cql-identifier",
            "expression": "Initial Population"
          }
        }
      ]
    }
  ]
}